Literature DB >> 14269435

ENTEROVIRAL SYNDROMES IN TORONTO, 1964.

D M MCLEAN, R P LARKE, G A MCNAUGHTON, P SMITH.   

Abstract

Virological or serological investigations of 72 children in Toronto and environs, who were hospitalized between January and October 1964 with a variety of syndromes, revealed evidence of enteroviral infection in 29 subjects. Coxsackie B2 was the dominant enterovirus, being isolated from feces and/or cerebrospinal fluid (CSF) of three children with aseptic meningitis, three with pleurodynia, one with myalgia and one with pericarditis; four additional patients showed rising antibody titres to this virus. Coxsackie B1 virus, which has not been isolated in Toronto since 1950, was recovered from feces of three patients with pleurodynia, CSF of one patient with myalgia, and peritoneal fluid of a child with primary peritonitis; one patient with pericarditis showed a rising antibody titre to Coxsackie B1 virus. Coxsackie B3, B4 and Echo 23 viruses were associated with one case each of pleurodynia. Coxsackie B5 virus infected five patients with aseptic meningitis, and one each with pericarditis and myocarditis.

Entities:  

Keywords:  CANADA; CHILD; COXSACKIE VIRUS INFECTIONS; ECHO VIRUSES; EPIDEMIOLOGY; MENINGITIS; MYOCARDITIS; PERICARDITIS; PERITONITIS; PLEUROPNEUMONIA; POLIOMYELITIS, BULBAR; STATISTICS

Mesh:

Year:  1965        PMID: 14269435      PMCID: PMC1928261     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  AN INFANT FATALITY ASSOCIATED WITH COXSACKIE B1 VIRUS.

Authors:  H T WRIGHT; K OKUYAMA; R M MCALLISTER
Journal:  J Pediatr       Date:  1963-09       Impact factor: 4.406

2.  Fatal neonatal infection due to Coxsackie B2 virus. Report of generalized infection and myocarditis in the newborn.

Authors:  G ROBINO; A PERLMAN; Y TOGO; J REBACK
Journal:  J Pediatr       Date:  1962-12       Impact factor: 4.406

3.  Properties of ECHO types 22, 23 and 24 viruses.

Authors:  R WIGAND; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1961

4.  Coxsackie B5 virus in association with pericarditis and pleurodynia.

Authors:  D M McLEAN; S J WALKER; H W BAIN
Journal:  Can Med Assoc J       Date:  1958-11-15       Impact factor: 8.262

5.  A near-fatal case of Coxsackie B1 myocarditis (with pericarditis) in an adult.

Authors:  A L AGRANAT
Journal:  S Afr Med J       Date:  1961-10-07

6.  Patterns of infection with enteroviruses.

Authors:  D M McLEAN
Journal:  J Pediatr       Date:  1959-06       Impact factor: 4.406

7.  An outbreak of a summer febrile disease caused by Coxsackie B-2 virus.

Authors:  A D HEGGIE; I SCHULTZ; R R GUTEKUNST; M ROSENBAUM; L F MILLER
Journal:  Am J Public Health Nations Health       Date:  1960-09

8.  EPIDEMIC COXSACKIE VIRUS INFECTION WITH MIXED CLINICAL MANIFESTATIONS.

Authors:  M S ARTENSTEIN; F C CADIGAN; E L BUESCHER
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

9.  Aspects meningitis; evidence for the etiologic role of Coxsackie B and orphan viruses.

Authors:  A J RHODES; A BEALE
Journal:  Ann N Y Acad Sci       Date:  1957-04-19       Impact factor: 5.691

10.  Enterovirus Infections in Toronto, 1959.

Authors:  D M McLean; S J Walker; G A McNaughton
Journal:  Can Med Assoc J       Date:  1960-03-26       Impact factor: 8.262

View more
  3 in total

1.  Acute cerebellar ataxia associated with the isolation of coxsackievirus type A9.

Authors:  W Feldman; R P Larke
Journal:  Can Med Assoc J       Date:  1972-05-20       Impact factor: 8.262

Review 2.  A Review and Update on Waterborne Viral Diseases Associated with Swimming Pools.

Authors:  Lucia Bonadonna; Giuseppina La Rosa
Journal:  Int J Environ Res Public Health       Date:  2019-01-09       Impact factor: 3.390

Review 3.  Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review.

Authors:  Haiting Lin; Lizhi Chen; Songyang Wen; Zhihui Yue; Ying Mo; Xiaoyun Jiang; Liuyi Huang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.